TY - JOUR JO - EuroIntervention TI - Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> In recent years, intracoronary bolus abciximab has emerged as an alternative to the standard intravenous route in patients with ST-elevation myocardial infarction (STEMI) underg AU - Piccolo Raffaele AU - Eitel Ingo AU - Iversen Allan Zeeberg AU - Gu Youlan L AU - Dominguez-Rodriguez Alberto AU - de Smet Bart J.G.L. AU - Mahmoud Karim D. AU - Abreu-Gonzalez Pedro AU - Thiele Holger AU - Piscione Federico VL - 9 IS - 9 Y1 - 20/01/2014 Y1 - 2014 DOI - SP - 1110 EP - 1120 KW - acute myocardial infarction KW - glycoprotein iib/iiia inhibitors KW - intracoronary abciximab KW - primary pci PB - Europa Digital & Publishing SE - Expert review UR - https://eurointervention.pcronline.com/article/intracoronary-versus-intravenous-bolus-abciximab-administration-in-patients-undergoing-primary-percutaneous-coronary-intervention-with-acute-st-elevation-myocardial-infarction-a-pooled-analysis-of-individual-patient-data-from-five-randomised-controlled-trials SN - 1774-024X ER -